COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS
申请人:[en]NMD PHARMA A/S
公开号:WO2024121130A1
公开(公告)日:2024-06-13
The present disclosure relates to compounds suitable for treating, ameliorating and/or preventing neuromuscular disorders, including the reversal of drug-induced neuromuscular blockade. The compounds as defined herein can inhibit the CIC-1 ion channel.
1,4-Benzothiazine-2-carboxylic acid 1-oxides as analogues of antibacterial quinolones
作者:Violetta Cecchetti、Arnaldo Fravolini、Fausto Schiaffella、Oriana Tabarrini、Weicheng Zhou、Pier Giuseppe Pagella
DOI:10.1002/jhet.5570290215
日期:1992.3
The synthesis of 1,4-benzothiazine-2-carboxylicacid1-oxides as agents which mimic quinoloneantibacterial, are described. The key step includes intramolecular cyclization of phenylsulfinyl acrylates 17 and 18 which are prepared in six steps from 11. None of new target compounds showed interesting antibacterial activity in vitro against the tested strains.